Dismiss Modal
David P. Galloway, MD

David P. Galloway, MD

Gastroenterologist/Hepatology/Nutrition
Assistant Professor

Office Locations

Assistant Professor

About Me

Dr. Galloway received his undergraduate degree from Texas A&M University in College Station, Texas. He then pursued his medical education at Texas A&M Health Science Center College of Medicine, graduating in 2009. Following medical school, Dr. Galloway completed training in general pediatrics from Phoenix Children’s Hospital Medical Center in 2012, which was followed by fellowship training in pediatric gastroenterology at Cincinnati Children’s Hospital Medical Center in 2015. Dr. Galloway is board certified in both general pediatrics and pediatric gastroenterology. He joined UAB and Children’s of Alabama in 2015 and is currently serving as Medical Director for the Center of Advanced Intestinal Rehabilitation.

Education

  • Residency: Phoenix Children’s Hospital
  • Medical School: Texas A&M Health Science Center College of Medicine (2009)
  • Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
  • Internship: Phoenix Children’s Hospital
  • UnderGraduate: Texas A&M University

Board Certifications

  • American Board of Pediatrics: Pediatrics (1970)
  • American Board of Pediatrics - Pediatric Gastroenterology (1970)

Languages Spoken

Spanish

Interests

Intestinal failure, Intestinal Rehabilitation, Nutrition, Improvement science

Professional Organizations

NASPGHAN, AAP, A.S.P.E.N., IHI

Publications

1. Chen WH, Cohen MB, Kirkpatrick BD, Brady RC, Galloway D, et al. Single-Dose Live Oral cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection with Bvirio cholera O1 El Tor. Clin Infect Dis. 2016 Mar 21 (Epub ahead of print). PMC4872293. 2. Galloway D, Danziger-Isakov L, Goldschmidt M, Hemmelgarn T, Courter J, Nathan J, Alonso M, Tiao G, Fei L, Kocoshis S. Incidence of bloodstream infections in small bowel transplant recipients receiving selective decontamination of the digestive tract: A single center experience. Pediatr Transplant. 2015 Nov; 19(7):722-9. PMC4837460. 3. David P. Galloway MD, Misty L. Trout MS, Samuel A. Kocoshis MD, Andrew T. Gewirtz PhD, Thomas R. Ziegler MD, Conrad R. Cole MD, MPH. “Increased anti-flagellin- and anti-lipopolysaccharide immunoglobulins in pediatric intestinal failure: Associations with fever and central line-associated blood-stream infections”. (Epub ahead of print; accepted for publication in JPEN, May 2014). PMC4623326. 4. Larsen, MD, Reagan, David Galloway, MD, Sheetal Wadera, MD, Dean Kjar, MS, David Hardy, MD, Curtis Mirkes, DO, Lori Wick, MD, and John Pohl, MD. "Safety of Propofol Sedation for Pediatric Outpatient Procedures." Clinical Pediatrics 48.8 (2009): 819-823. PMID 19483136.